Cargando…

Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales: Maggio, Roberto, Corsini, Giovanni U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175911/
https://www.ncbi.nlm.nih.gov/pubmed/32334052
http://dx.doi.org/10.1016/j.phrs.2020.104837
_version_ 1783524924919382016
author Maggio, Roberto
Corsini, Giovanni U.
author_facet Maggio, Roberto
Corsini, Giovanni U.
author_sort Maggio, Roberto
collection PubMed
description
format Online
Article
Text
id pubmed-7175911
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71759112020-04-22 Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection Maggio, Roberto Corsini, Giovanni U. Pharmacol Res Article Elsevier Ltd. 2020-07 2020-04-22 /pmc/articles/PMC7175911/ /pubmed/32334052 http://dx.doi.org/10.1016/j.phrs.2020.104837 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Maggio, Roberto
Corsini, Giovanni U.
Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection
title Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection
title_full Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection
title_fullStr Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection
title_full_unstemmed Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection
title_short Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection
title_sort repurposing the mucolytic cough suppressant and tmprss2 protease inhibitor bromhexine for the prevention and management of sars-cov-2 infection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175911/
https://www.ncbi.nlm.nih.gov/pubmed/32334052
http://dx.doi.org/10.1016/j.phrs.2020.104837
work_keys_str_mv AT maggioroberto repurposingthemucolyticcoughsuppressantandtmprss2proteaseinhibitorbromhexineforthepreventionandmanagementofsarscov2infection
AT corsinigiovanniu repurposingthemucolyticcoughsuppressantandtmprss2proteaseinhibitorbromhexineforthepreventionandmanagementofsarscov2infection